John S. McBride
CIK 1618251 · Chief Operating Officer · last filed 2026-01-16
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$12.2K
Companies
3
Total Filings
13
Lifetime Open-Market Net
-$315.2K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ELDN | Director | 3,430 | $3.57 | $12.2K | $0 | 5 | 2026-01-16 |
| Eledon Pharmaceuticals, Inc. (NVUS) Delisted | Director | — | — | — | $0 | 4 | 2020-09-15 |
| Eledon Pharmaceuticals, Inc. (TKAI) Delisted | Chief Operating Officer | 0 | — | — | -$315.2K | 4 | 2015-12-17 |
Recent Filings · Page 2 of 2
13 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-09-22 | Eledon Pharmaceuticals, Inc. (TKAI) Delisted | Mixed | — | -$132.6K | EDGAR |
| 2015-06-24 | Eledon Pharmaceuticals, Inc. (TKAI) Delisted | Mixed | — | -$88.4K | EDGAR |
| 2014-10-17 | Eledon Pharmaceuticals, Inc. (TKAI) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 11–13 of 13
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.